“Advancing preclinical research at full speed”

InTouch Bio (A Division of InTouch BioSolutions LLC) 2012 ©  All rights reserved.   

Neurology Research
Immunology Research
Toxicology Testing
Model Evaluation
PK/PD Evaluation
Oncology Research
Today’s date: February 6, 2012
Welcome.
Services.
Our Facility.
About Us.
Contact Us.
Welcome.
Services.
Our Facility.
About Us.
Contact Us.

InTouch Bio is a division of InTouch BioSolutions LLC and based in Alameda, CA. Established in 2008, InTouch BioSolutions provides enabling services in drug R&D and preclinical research services.

Jay Dela Cruz, Ph.D. is President and Founder of InTouch BioSolutions LLC. He continues to participate hands-on and serves as Scientific Director for both CellSpecific™ and InTouch Bio.

 

Dr. Dela Cruz has worked with various ex-vivo and in-vivo models that have led to an invention and numerous publications. At Genentech, Inc. and KAI Pharmaceuticals, Inc. he evaluated candidate antibody, small molecule- and peptide-based therapeutics against cancer and various autoimmune diseases in vivo. He also developed clinically-relevant drug biomarkers.

 

In 2008, Dr. Dela Cruz established CellSpecific™ to offer cell-based assay and drug biomarker development and validation along with cell isolation and cell differentiation services. Dr. Dela Cruz established InTouch Bio in June of 2010 to meet the growing demand for preclinical research services.

About InTouch Bio

Leadership

InTouch Bio now provides the reliable and robust unilateral 6-OHDA striatal or substantia nigra lesion rat model more.

Parkinson’s Disease Research at InTouch Bio